Peter Smith‐Jones
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Medical Imaging Techniques and Applications
- Monoclonal and Polyclonal Antibodies Research
- Cancer Research top 1%
- MicroRNA in disease regulation
Papers in
-
- Radiopharmaceutical Chemistry and Applications 33
- Monoclonal and Polyclonal Antibodies Research 9
- Epidemiology 21
- Neuroendocrine Tumor Research Advances 19
- Co-authors
- Steven M. Larson (33 shared papers)Neil H. Bander (10 shared papers)Thomas J. Anchordoquy (2 shared papers)Michael W. Graner (2 shared papers)Tyson Smyth (2 shared papers)Charles L. Sawyers (2 shared papers)John Wongvipat (2 shared papers)Howard I. Scher (7 shared papers)
- Journals
- Journal of Nuclear Medicine (8 papers)Nuclear Medicine and Biology (5 papers)European Journal of Nuclear Medicine and Molecular Imaging (4 papers)PLoS ONE (3 papers)Journal of Controlled Release (2 papers)
- Partner nations
- United StatesSwitzerlandAustria
In The Last Decade
Peter Smith‐Jones
87 papers receiving 7.5k citations
Peter Smith‐Jones's Hit Papers
Peers
Comparison fields: 5 of 125
- Radiology, Nuclear Medicine and Imaging 2.8k
- Cancer Research 1.4k
- Pulmonary and Respiratory Medicine 2.7k
- Oncology 1.6k
- Molecular Biology 2.4k
Countries citing papers authored by Peter Smith‐Jones
This map shows the geographic impact of Peter Smith‐Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Smith‐Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Smith‐Jones more than expected).
Fields of papers citing papers by Peter Smith‐Jones
This network shows the impact of papers produced by Peter Smith‐Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Smith‐Jones. The network helps show where Peter Smith‐Jones may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Smith‐Jones, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer Hit paper breakdown → | 2009 | 1756 |
| 2 | Biodistribution and delivery efficiency of unmodified tumor-derived exosomes Hit paper breakdown → | 2014 | 626 |
| 3 | 2014 | 440 | |
| 4 | 2010 | 355 | |
| 5 | 2011 | 260 | |
| 6 | 2004 | 245 | |
| 7 | 2011 | 241 | |
| 8 | 2003 | 207 | |
| 9 | 2009 | 195 | |
| 10 | In vitro characterization of radiolabeled monoclonal antibodies specific for the extracellular domain of prostate-specific membrane antigen. | 2000 | 180 |
| 11 | 2005 | 160 | |
| 12 | Radiolabeled monoclonal antibodies specific to the extracellular domain of prostate-specific membrane antigen: preclinical studies in nude mice bearing LNCaP human prostate tumor. | 2003 | 153 |
| 13 | Early tumor response to Hsp90 therapy using HER2 PET: comparison with 18F-FDG PET. | 2006 | 138 |
| 14 | 2003 | 118 | |
| 15 | 1998 | 117 | |
| 16 | Gallium-67/gallium-68-[DFO]-octreotide--a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. | 1994 | 114 |
| 17 | 2005 | 99 | |
| 18 | 2010 | 97 | |
| 19 | 2011 | 78 | |
| 20 | 2012 | 77 |
About Peter Smith‐Jones
Peter Smith‐Jones is a scholar working on Radiology, Nuclear Medicine and Imaging, Epidemiology, Pulmonary and Respiratory Medicine, Oncology and Neurology, having authored 87 papers that have together received 7.7k indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (33 papers), Neuroendocrine Tumor Research Advances (19 papers), Neuroblastoma Research and Treatments (11 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Lung Cancer Research Studies (8 papers), Prostate Cancer Treatment and Research (7 papers), Cancer, Hypoxia, and Metabolism (6 papers) and HER2/EGFR in Cancer Research (4 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (2.8k citations), Cancer Research (1.4k citations), Pulmonary and Respiratory Medicine (2.7k citations), Oncology (1.6k citations) and Molecular Biology (2.4k citations). Peter Smith‐Jones has collaborated with scholars based in United States, Switzerland and Austria. Frequent co-authors include Steven M. Larson, Neil H. Bander, Thomas J. Anchordoquy, Michael W. Graner, Tyson Smyth, Charles L. Sawyers, John Wongvipat, Howard I. Scher, Noeen Malik and Max Kullberg. Their work appears in journals such as Journal of Nuclear Medicine, Nuclear Medicine and Biology, European Journal of Nuclear Medicine and Molecular Imaging, PLoS ONE and Journal of Controlled Release.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.